Press Releases

Healthcare providers from across Texas gathered today for a press conference at the State Capitol to highlight current negative trends in health insurance and protest harmful business practices by insurers to pay less for emergency care and shift healthcare costs directly to consumers.

Carestream will demonstrate its CARESTREAM OnSight 3D Extremity System (see video link) that uses cone beam CT (CBCT) technology to capture high-quality, low-dose 3D extremity exams at the American College of Sports Medicine (ACSM) annual meeting that begins May 30. This conference is one of the largest sports medicine and exercise science conferences in the world.

WALTHAM, MA, May 4, 2017 – A multi-center post-hoc analysis presented at the American Association of Clinical Endocrinologists (AACE) 26th Annual Scientific & Clinical Congress by Drs. Jagdeesh Ullal and Joseph Aloi demonstrates that Glytec’s eGlycemic Management System® (eGMS®) enables hospitals to achieve the basal bolus standard of care for subcutaneous insulin therapy with extraordinary efficiency and superior patient outcomes. The new research study, entitled ‘AUTO Study, AUtomatic Titration tO Target: Subcutaneous Basal Bolus Insulin Management Using eGMS in the Non-ICU Setting,’ observed a 19% reduction in average daily blood glucose between admission and discharge -- with 0.00% severe hypoglycemia <40 mg/dL -- while achieving the prescribed target blood glucose of 140-180 mg/dL at all mealtime and bedtime intervals.

Innovaccer Inc., a Silicon Valley-headquartered healthcare analytics company, launched a free tool, the Social Determinants of Health Portal, designed to help providers understand and monitor the impacts of social determinants of health on patient population across every county and work towards achieving better health outcomes.

Exsurco® Medical, Inc. announces the launch of a new wound debridement and skin grafting medical device designed for use in burn and trauma centers. Backed by Exsurco’ s knowledge and ground breaking design and innovation, the new Amalgatome® SD is a revolutionary break-through in combining skin grafting and wound debridement technology in an industry that hasn’t seen this kind of innovation for a multiple use device. By using one device for multiple procedures (excision and/or auto grafting), the Amalgatome SD helps those who are in critical need of the healing power of skin.

&nbsp;As we consider the renewed effort to &quot;repeal and replace&quot; the Affordable Care Act (ACA), it is important to acknowledge both its successes and its flaws.

Southern Hills Hospital announces that a new Family Medicine Residency Graduate Medical Education (GME) program received initial accreditation from the Accreditation Council for Graduate Medical Education (ACGME). ACGME is a private, non-profit organization that evaluates and accredits graduate medical education programs.&nbsp;

On behalf of more than one hundred million Americans battling chronic and other major health conditions,&nbsp;the following coalition of 10 patient organizations remains united in its opposition to the American Health Care Act (AHCA)

G4S has launched an innovative portable security system to monitor the safety of vulnerable patients.

ImagineSoftware today announced it has entered into a strategic agreement with Merge, an IBM company. ImagineSoftware will assume frontline support for Merge Financials and Merge Sentinel customers, and will provide an option for those customers to upgrade to Imagine&#39;s innovative platform for medical billing automation.

The study will examine the immuno-genetic underpinnings of the respiratory infection caused by inhalation of fungal spores&mdash;known as Coccidioides&mdash;endemic to soils of the U.S. Southwest.&nbsp;

The growing demand for quality healthcare has revolutionised the health monitoring space through use of wearable and ingestible sensors. Emphasis on preventive health has lead to the development of prognostic sensors for applications in medical space. This has lead to the shift of healthcare business model from a diagnostic one to more prognostic and preventive health and wellness. Sensor adoption is crucial to this evolution, facilitating advanced diagnostics, treatment, and patient monitoring. Wearable and implantable biosensors will emerge as the key enablers for device innovation, as well as will be commercialised as prognostic tools.

In a new analysis funded by Physicians for Fair Coverage, researchers at NORC at the&nbsp;University of Chicago, an independent research organization, today announced&nbsp;results of a study&nbsp;that found the FAIR Health database currently offers advantages over other national datasets and state All Payers Claims Data (APCDs) for the purpose of identifying a standard benchmark for out-of-network physician rates for medical services.

The American Medical Association (AMA) said today it looks forward to working with the Trump Administration as it implements a new strategy for combating the nation&rsquo;s opioid epidemic. Health and Human Services (HHS) Secretary Tom Price outlined the strategy Wednesday at the National Rx Drug Abuse &amp; Heroin Summit.&nbsp;

Providers who want to take advantage of value-based reimbursements and avoid MACRA penalties in 2018 must act fast &ndash; Caravan Health, the market leader in Accountable Care Organizations (ACOs), has extended its deadline for consideration in a 2018 ACO to April 30, 2017.

Building on their recent research focusing on a peptide, pNaKtide, designed to block the oxidant amplifying function of the cellular sodium-potassium pump, researchers&nbsp;at Marshall University Joan C. Edwards School of Medicine&nbsp;have successfully demonstrated that pNaKtide can attenuate the development of experimental nonalcoholic fatty liver disease (NAFLD) and atherosclerosis.

DePuy Synthes Products, Inc., part of the Johnson &amp; Johnson Family of Companies, has acquired 3D printing technology from Tissue Regeneration Systems, Inc. (TRS). The 3D printing methods developed by TRS will help enable DePuy Synthes to create patient-specific, bioresorbable implants with a unique mineral coating intended to support bone healing in patients with orthopaedic and craniomaxillofacial deformities and injuries. Financial terms of the transaction have not been disclosed.

Oncology community professionals are concerned about the ability of their patients to access cancer screening and treatment under the proposed American Health Care Act, according to a survey conducted March 23–24, 2017 at the National Comprehensive Cancer Network® (NCCN®) 22nd Annual Conference: Improving the Quality, Effectiveness, and Efficiency of Cancer Care™ at the Rosen Shingle Creek in Orlando, Florida.

As a Bronze Sponsor of the National Rx Drug Abuse and Heroin Summit, Proove® Biosciences, Inc. announces the first-ever peer-reviewed published clinical study analyzing genetics, environmental, and lifestyle factors to accurately predict prescription opioid abuse.

electroCore, a neuroscience and technology company dedicated to improving patient outcomes through technological advancement, announced today that the U.S. Food and Drug Administration (FDA) released the use of gammaCore® (non-invasive vagus nerve stimulator) for the acute treatment of pain associated with episodic cluster headache in adult patients. gammaCore transmits a mild electrical stimulation to the vagus nerve through the skin, resulting in a reduction of pain. This is the first FDA product release for electroCore in the U.S.

Hundreds of emergency and mobile healthcare professionals, representing emergency medical services (EMS) in almost every U.S. state, will assemble on Capitol Hill to request support from congressional leaders on issues vital to the health and safety of every community in our nation.